Orchestra BioMed Statistics
NASDAQ: OBIOHealth Care Medicinal Chemicals and Botanical Products USD
6.58-0.42 (-6.00%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Orchestra BioMed by the numbers
Orchestra BioMed has a market capitalization of $517.9 million based on 78.70M shares outstanding. With trailing EPS of $-0.75, Orchestra BioMed is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 9.5% above its 50-day average and 39.7% above its 200-day average.
Average daily trading volume is 420.19K shares, or about $2.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
OBIO valuation vs. peer median
| Metric | OBIO | Peer median | Difference |
|---|---|---|---|
| Market cap | $517.88M | $217.40M | +138% |
| Avg. volume | 420.19K | 1.29M | -67% |
Peer median across 8 companies: SNDL, TLRY, ACB, USNA, MDWD, CGC, NAGE, GLAS.
Valuation
- Market cap
- $517.88M
- Price / sales (latest FY)
- 15.47
- EPS (TTM)
- $-0.75
- Shares outstanding
- 78.70M
Price and trading
- Previous close
- 7.00
- Open
- 6.89
- Day range
- 6.47 – 7.14
- 52-week range
- 3.46 – 7.83
- 52-week change
- +45.25%
- Beta
- —
- Volume
- 554.32K
- Average volume
- 420.19K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 10, 2026
Additional statistics
- Market Cap
- 517.88M
- Forward Pe
- -5.17
- Eps
- -0.75
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 7.83
- Week52 Low
- 3.46
- Avg Volume
- 420.19K
- Shares Outstanding
- 78.70M
- Ma50
- 6.01
- Ma200
- 4.71
- Earnings Date
- Nov 10, 2026
- Pct From52w High
- -15.91%
- Pct From52w Low
- 90.17%